Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase 2 4Phase 1 4Phase 3 2Phase NA 1

Status

Active not recruiting 2Recruiting 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 170Neoplasm Metastasis 139Neoplasms 136Leukemia, Myeloid, Acute 133Colorectal Neoplasms 115Breast Neoplasms 115Melanoma 90Ovarian Neoplasms 88Prostatic Neoplasms 85Recurrence 83Multiple Myeloma 81Lung Neoplasms 73Squamous Cell Carcinoma of Head and Neck 72Glioblastoma 71Pancreatic Neoplasms 70Myelodysplastic Syndromes 63Lymphoma, Non-Hodgkin 59Triple Negative Breast Neoplasms 53Glioma 53Stomach Neoplasms 49Endometrial Neoplasms 46Brain Neoplasms 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Lymphoma, Large B-Cell, Diffuse 45Carcinoma, Renal Cell 45Small Cell Lung Carcinoma 44Lymphoma, Follicular 40Lymphoma, B-Cell 40Carcinoma, Hepatocellular 40Sarcoma 39

Interventions

ibrutinib 1gallium 68 PSMA-11 1enzalutamide 1darolutamide 1Rosuvastatin Calcium 1Pioglitazone 1JNJ-64619178 1JNJ-64264681 1(225)Ac-PSMA-617 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms, Castration-Resistant × 90 days × Clear all
NCT02592317 2026-05-08

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Aragon Pharmaceuticals, Inc.

Phase 1 Active not recruiting
23 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT06788509 2026-05-08

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Janssen Research & Development, LLC

Phase 1 Enrolling by invitation
120 enrolled
GenitourinaryLymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Prostatic Neoplasms, Castration-Resistant

NCT04597411 2026-04-30

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

Endocyte

Phase 1 Active not recruiting
101 enrolled
Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05997615 2026-04-20

AMX-500

Vir Biotechnology, Inc.

Phase 1 Recruiting
390 enrolled
Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡